ketamine with bupivacaine vs bupivacaine analgesia in breast surgeries

A Randomized Prospective study to see the Efficacy and Safety of KETAMINE added to BUPIVACAINE 0.25% in USG guided Modified Pectoral Block for management of postoperative pain in patients undergoing Modified Radical Mastectomy - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063084

Enrollment

Registered

2024-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: ketamine with bupivacaine: Before surgical resection patients will be receiving the study drugs according to group allocated. Patients will be randomly allocated to group BK using table

Eligibility

Inclusion criteria

Inclusion criteria: 1.females undergoing breast cancer surgery. 2.ASA grade I and II.

Exclusion criteria

Exclusion criteria: 1.Patient refusal. 2.Deranged coagulation profile. 3.History of opioid use or addiction. 4.Obesity 5.Pregnancy.

Design outcomes

Primary

Measure	Time frame
duration of analgesiaTimepoint: immediate post operation baseline, 30mnts,1hr,2hr,4hr,6hr,12hr,24hr	—

Secondary

Measure	Time frame
1.Total postoperative analgesic consumption. 2.Haemodynamic variable and side effectsTimepoint: immediate post operation baseline, 30mnts,1hr,2hr,4hr,6hr,12hr,24hr	—

Countries

India

Contacts

Public ContactDr VEENA PATODI

Jawahar Lal Nehru Medical College

veenapatodi@gmail.com9414008276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026